SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NOW who wrote (100465)8/6/2009 3:36:32 PM
From: Casaubon  Read Replies (1) of 116555
 
By the way, she's right about one thing...The prices drug companies charge have little relationship to the costs of making the drugs.

Instead, the price of drugs has everything to do with the cost of inventing those drugs and proving they work (safely), by running expensive clinical trials. In fact, after spending more than ten years on average developing a drug, approximately 90% of the candidates fail in clinical trials, for a multitude of reasons. It now costs in the vicinity of one billion dollars to develop a new drug (and the number of successful clinical candidates has fallen in half over the last decade, due to the extreme difficulties in elucidating valid drug targets and the subsequent difficulties of finding a safe and effective solution. The good news is that drugs are becoming more efficacious. IMO, you should pray that a drug exists for any afflictions you run across.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News